Ongoing Pharmacological Developments in <i>SLC6A1</i> Research & Treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ongoing Pharmacological Developments in SLC6A1 Research & Treatment

Published:2024-08-16 Issue: Volume: Page:
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

DeLeeuw Melissa B.¹²³⁴,Tiller Jacob⁵⁶,Kang Jing‐Qiong¹³⁴,Freed Amber⁵

Affiliation:

1. Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology Meharry Medical College Nashville Tennessee USA

2. Department of Biomedical Sciences Meharry Medical College Nashville Tennessee USA

3. Department of Neurology Vanderbilt University Medical Center Nashville Tennessee USA

4. Vanderbilt Brain Institute Nashville Tennessee USA

5. SLC6A1 Connect Organization Dallas Texas USA

6. Brown University Providence Rhode Island USA

Publisher

Wiley

Link

https://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.3413

Reference9 articles.

1. DeSantis R.A treatment didn't exist for her Son's rare disease—so one mom raised millions to cure itPeoplemag (2020).

2. Molecular and clinical repercussions of GABA transporter 1 variants gone amiss: links to epilepsy and developmental Spectrum disorders;Fischer F.;Frontiers,2022

3. Philadelphia TCH of.SLC6A1‐related disorderswww.chop.edu.2020. .

4. SLC6A1 variant pathogenicity, molecular function and phenotype: a genetic and clinical analysis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP